Biomed Diagnostics Revenue and Competitors

First conceived in 1989, Biomed Diagnostics is the resulting collaboration between two physicians who found themselves vulnerable without necessary equipment during a mercy mission in Central America. Without refrigeration, practical supplies, or laboratory instrumentation to identify organisms which were causing illness in local population, they set about researching and developing innovative point-of-care devices which could be easily packaged and contained. Their efforts over a 7-year pursuit culminated in the first InPouch® and later InTray® culture systems. These fully enclosed tools provided an in-field solution to human and animal infections in third-world countries, ranches, and rural communities. In 1996, the patents were obtained by Robert Hall and Jane Hall, the founding partners of Biomed Diagnostics. Specimen inoculation, culture, transport, and presumptive result could now be done in a single device, allowing medical professionals to accurately detect and differentiate various pathogens. Today, Biomed Diagnostics honors our origin and is dedicated to combating health threats around the globe by providing the CDC and global health organizations tools in the surveillance of antibiotic-resistant microorganisms.